Table 3.
Laboratory tests (median [25th %ile, 75th %ile]) at the time of diagnosis of giant cell arteritis (GCA), comparing statin users and non-users (Wilcoxon rank sum test). N is the number of subjects with result available for the considered parameter.
| 0 | GCA with statin (n = 54) | n | GCA without statin (n = 243) | n | p |
|---|---|---|---|---|---|
| ESR (mm/h) | 64 [53–96] | 54 | 69 [43–95] | 237 | 0.9 |
| CRP (mg/L) | 48.7 [35–94.6] | 38 | 56.5 [27–100] | 150 | 0.8 |
| Hemoglobin (g/dl) | 11.6 [10.5–12.5] | 47 | 11.7 [10.7–12.8] | 227 | 0.4 |
| Platelets (.109/l) | 383 [301–438] | 47 | 378 [318–462] | 226 | 0.4 |
| Leucocytes (.109/l) | 8.6 [6.8–10.3] | 47 | 8.9 [7.4–11.3] | 226 | 0.1 |
| Cholesterol total (mg/dl) | 170 [146.5–207.5] | 36 | 190 [166–219] | 134 | 0.04 |
| HDL–Cholesterol (mg/dl) | 59 [41.5–70.5] | 36 | 58 [45–72] | 133 | 0.6 |
| LDL-Cholesterol (mg/dl) | 88 [75–108] | 36 | 107 [88–130] | 133 | 0.004 |
| Triglycerides (mg/dl) | 107 [87–161] | 36 | 101 [75–142] | 133 | 0.3 |
ESR = erythrocyte sedimentation rate; CRP = C-reactive protein